spacer gif spacer gif spacer gif spacer gif spacer gif
 QUICK SEARCH:   [advanced]


spacer gif
     Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents    

First published online May 4, 2004


Journal of Cell Science 117, 1101e (2004)
© The Company of Biologists Limited
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in JCS
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

In this issue

A lysosomal cut to heparanase activity


Heparanase, an endo-ß-D-glucuronidase that cleaves heparan sulphate and participates in extracellular matrix regulation, is upregulated in many primary human tumours and tumour-derived cell lines. It is produced as an inactive 65 kDa precursor that is cleaved into 50 kDa and 8 kDa subunits, which heterodimerize to form the active enzyme. To investigate heparanase processing, Israel Vlodavsky, Neta Ilan and co-workers have raised a polyclonal antibody to a 14-residue peptide in the N-terminus of the 50 kDa subunit (see p. 2249). They use this to show that, when the 65 kDa precursor is added to cells, both the 50 kDa subunit and the 65 kDa precursor localize to lysosomes. Because heparanase processing is sensitive to lysosomal protease inhibitors, the authors conclude that heparanase is activated in lysosomes rather than at the plasma membrane as previously suggested. Furthermore, because the polyclonal antibody inhibits heparanase activity, they suggest that monoclonal antibodies against the same epitope could help to tease out the normal and pathological roles of heparanase.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?

Related articles in JCS:

Processing and activation of latent heparanase occurs in lysosomes
Anna Zetser, Flonia Levy-Adam, Victoria Kaplan, Svetlana Gingis-Velitski, Yulia Bashenko, Shay Schubert, Moshe Y. Flugelman, Israel Vlodavsky, and Neta Ilan
JCS 2004 117: 2249-2258. [Abstract] [Full Text]  




This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in JCS
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?